Halogen bonding at the ATP binding site of protein kinases: preferred geometry and topology of ligand binding.

Halogenated ligands have been widely developed as potent, and frequently selective, inhibitors of protein kinases (PK). Herein, all structures of protein kinases complexed with a halogenated ligand, identified in the PDB, were analyzed in the context of eventual contribution of halogen bonding to protein-ligand interactions. Global inspection shows that two carbonyl groups of residues located in the hinge region are the most abundant halogen bond acceptors. In contrast to solution data, well-defined water molecules, located at sites conserved across most PK structures, are also involved in halogen bonding. Analysis of cumulative distributions of halogen-acceptor distances shows that structures displaying short contacts involving a halogen atom are overpopulated, contributing together to clearly defined maxima of 2.82, 2.91 and 2.94Å for chlorine, bromine and iodine, respectively. The angular preference of a halogen bond favors ideal topology (180°, 120°) for iodine. For bromine the distribution is much more dispersed, and no such preference was found for chlorine. This article is part of a Special Issue entitled: Inhibitors of Protein Kinases (2012).

[1]  R. Eckenhoff,et al.  Molecular interactions between inhaled anesthetics and proteins. , 1997, Pharmacological reviews.

[2]  J. Poznański,et al.  Relative role of halogen bonds and hydrophobic interactions in inhibition of human protein kinase CK2α by tetrabromobenzotriazole and some C5-substituted analogues. , 2010, Journal of Physical Chemistry B.

[3]  P Shing Ho,et al.  Directing macromolecular conformation through halogen bonds , 2007, Proceedings of the National Academy of Sciences.

[4]  W. Herrebout,et al.  The C–Cl⋯N halogen bond, the weaker relative of the C–I and C–Br⋯N halogen bonds, finally characterized in solution , 2010 .

[5]  P. S. Ho,et al.  The role of halogen bonding in inhibitor recognition and binding by protein kinases. , 2007, Current topics in medicinal chemistry.

[6]  E. de Moliner,et al.  Structural features underlying selective inhibition of protein kinase CK2 by ATP site‐directed tetrabromo‐2‐benzotriazole , 2001, Protein science : a publication of the Protein Society.

[7]  Giuseppe Zanotti,et al.  Inspecting the structure-activity relationship of protein kinase CK2 inhibitors derived from tetrabromo-benzimidazole. , 2005, Chemistry & biology.

[8]  J. Bain,et al.  ATP site-directed inhibitors of protein kinase CK2: an update. , 2011, Current topics in medicinal chemistry.

[9]  L. Johnson,et al.  Alternative binding modes of an inhibitor to two different kinases. , 2003, European journal of biochemistry.

[10]  Adnan Memic,et al.  How Do Halogen Substituents Contribute to Protein‐Binding Interactions? A Thermodynamic Study of Peptide Ligands with Diverse Aryl Halides , 2008, Chembiochem : a European journal of chemical biology.

[11]  A. Konagurthu,et al.  MUSTANG: A multiple structural alignment algorithm , 2006, Proteins.

[12]  Mahmoud A. A. Ibrahim,et al.  Performance Assessment of Semiempirical Molecular Orbital Methods in Describing Halogen Bonding: Quantum Mechanical and Quantum Mechanical/Molecular Mechanical-Molecular Dynamics Study , 2011, J. Chem. Inf. Model..

[13]  Pierangelo Metrangolo,et al.  Halogen Bonding in Halocarbon—Protein Complexes: A Structural Survey , 2011 .

[14]  J. Poznański,et al.  Synthesis and physico-chemical properties in aqueous medium of all possible isomeric bromo analogues of benzo-1H-triazole, potential inhibitors of protein kinases. , 2012, The journal of physical chemistry. B.

[15]  D. Herschlag,et al.  Evaluating the potential for halogen bonding in the oxyanion hole of ketosteroid isomerase using unnatural amino acid mutagenesis. , 2009, ACS chemical biology.

[16]  Peter Politzer,et al.  Halogen bonding and the design of new materials: organic bromides, chlorides and perhaps even fluorides as donors , 2007, Journal of molecular modeling.

[17]  François Diederich,et al.  Systematic investigation of halogen bonding in protein-ligand interactions. , 2011, Angewandte Chemie.

[18]  S. Davies,et al.  Selectivity of 4,5,6,7‐tetrabromobenzotriazole, an ATP site‐directed inhibitor of protein kinase CK2 (‘casein kinase‐2’) , 2001, FEBS letters.

[19]  R. Eckenhoff,et al.  Structural basis for high‐affinity volatile anesthetic binding in a natural 4‐helix bundle protein , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  J. Poznański,et al.  Isomeric Mono-, Di-, and Tri-Bromobenzo-1H-Triazoles as Inhibitors of Human Protein Kinase CK2α , 2012, PloS one.

[21]  Eric Westhof,et al.  Halogen bonds in biological molecules. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[22]  D. Marquardt An Algorithm for Least-Squares Estimation of Nonlinear Parameters , 1963 .

[23]  J. Bain,et al.  The selectivity of inhibitors of protein kinase CK2: an update. , 2008, The Biochemical journal.

[24]  K. Rissanen Halogen bonded supramolecular complexes and networks , 2008 .

[25]  D. Shugar,et al.  Selectivity of 4,5,6,7-tetrabromobenzimidazole as an ATP-competitive potent inhibitor of protein kinase CK2 from various sources. , 2003, Biochemical and biophysical research communications.

[26]  M. Chudziński,et al.  Halogen bonding in solution: thermodynamics and applications. , 2013, Chemical Society reviews.

[27]  W. Herrebout,et al.  C-X···π halogen and C-H···π hydrogen bonding: interactions of CF3X (X = Cl, Br, I or H) with ethene and propene. , 2012, Physical chemistry chemical physics : PCCP.

[28]  P. S. Ho,et al.  Assaying the Energies of Biological Halogen Bonds , 2011 .

[29]  Mahmoud A A Ibrahim,et al.  AMBER empirical potential describes the geometry and energy of noncovalent halogen interactions better than advanced semiempirical quantum mechanical method PM6-DH2X. , 2012, The journal of physical chemistry. B.

[30]  P. Beer,et al.  Halogen Bonding in Supramolecular Chemistry. , 2008, Chemical reviews.

[31]  Mahmoud A. A. Ibrahim,et al.  Molecular mechanical study of halogen bonding in drug discovery , 2011, J. Comput. Chem..

[32]  Concentration-dependent Br...O halogen bonding between carbon tetrabromide and oxygen-containing organic solvents. , 2009, The journal of physical chemistry. A.

[33]  Weiliang Zhu,et al.  Utilization of halogen bond in lead optimization: a case study of rational design of potent phosphodiesterase type 5 (PDE5) inhibitors. , 2011, Journal of medicinal chemistry.

[34]  S. Moro,et al.  The ATP‐Binding Site of Protein Kinase CK2 Holds a Positive Electrostatic Area and Conserved Water Molecules , 2007, Chembiochem : a European journal of chemical biology.

[35]  Keehyoung Joo,et al.  Improving physical realism, stereochemistry, and side‐chain accuracy in homology modeling: Four approaches that performed well in CASP8 , 2009, Proteins.

[36]  James S. Duncan,et al.  Tetrabromobenzotriazole (TBBt) and tetrabromobenzimidazole (TBBz) as selective inhibitors of protein kinase CK2: evaluation of their effects on cells and different molecular forms of human CK2. , 2005, Biochimica et biophysica acta.

[37]  A. Ferguson,et al.  Structural basis of CX‐4945 binding to human protein kinase CK2 , 2011, FEBS letters.

[38]  P Voth Regier Andrea and Ho Shing,et al.  The role of halogen bonding in inhibitor recognition and binding by protein kinases. , 2007 .

[39]  K. Berka,et al.  On the reliability of the AMBER force field and its empirical dispersion contribution for the description of noncovalent complexes. , 2010, Chemphyschem : a European journal of chemical physics and physical chemistry.

[40]  Patric Schyman,et al.  Treatment of Halogen Bonding in the OPLS-AA Force Field; Application to Potent Anti-HIV Agents. , 2012, Journal of chemical theory and computation.

[41]  Xiang Zhu,et al.  How does halogen bonding behave in solution? A theoretical study using implicit solvation model. , 2011, The journal of physical chemistry. A.

[42]  S. Ragsdale,et al.  Transcriptional Activation of Dehalorespiration , 2006, Journal of Biological Chemistry.

[43]  Mohammed G. Sarwar,et al.  Thermodynamics of halogen bonding in solution: substituent, structural, and solvent effects. , 2010, Journal of the American Chemical Society.